You are here

Article Text

Article menu
Download PDFPDF
Correspondence
Paradoxical severe decrease in serum HDL-cholesterol after treatment with a fibrate
  1. A O Olukoga
  1. 9 Jayton Avenue, East Didsbury, Manchester M20 5QD, UK; AOlukoga@hotmail.com

    https://doi.org/10.1136/jcp.55.9.718-a

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      Crook et al recently reported a paradoxical decrease in serum high density lipoprotein-cholesterol (HDL-C) in a patient who was receiving fibrate (bezafibrate) treatment for hyperlipidaemia.1 Reviewing the literature, they rightly highlighted some of the characteristics that have so far been observed in association with this phenomenon, namely: (1) it occurs with fibrate monotherapy, in addition to when fibrates have been combined with other hypolipidaemic agents; (2) it appears to be a class effect of the fibric acid derivative group of drugs, having been seen with all the major fibrates; (3) there may sometimes be a …

      View Full Text